News for Dong-A Socio Holdings Co., Ltd. (000640.KS)

Published at

Aug 14, 2023 2:01 PM

by prnewswire.com

mixed

mixed

NEUROBO PHARMACEUTICALS APPOINTS HYUNG HEON KIM AS CHIEF EXECUTIVE OFFICER AND PRESIDENT

/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today...

170900.KS NRBO 096775.KS 096770.KS 000640.KS

Read more →
Published at

Nov 1, 2022 9:50 AM

by prnewswire.com

mixed

mixed

Phosphodiesterase (PDE) Inhibitors Market to Grow by USD 2.86 Bn, 40% of Market Growth to Originate from North America - Technavio

/PRNewswire/ -- The phosphodiesterase (PDE) inhibitors market size is expected to grow by USD 2.86 billion from 2021 to 2026. In addition, the growth momentum...

HKMPY HKMPF HIK.L AMGN.MX AMGN.BA AMGN AMG.DE ZEG.DE SUNPHARMA-BL.NS PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE GSK.L GSK GS7.DE GLAXF BAX.MX BAX AZNN.MX AZNCF AZN.L AZN 0QK8.L 0A4J.L 000640.KS

Read more →
Published at

Jul 12, 2021 2:31 PM

by marketscreener.com

mixed

mixed

NeuroBo Pharmaceuticals' : Shareholders Elect Hyung Heon Kim and Andrew I. Koven to NeuroBo's Board of Directors

BOSTON, July 12, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for... | July 12, 2021

NRBO KALA 0JQ2.L 000640.KS MRKD.BA MRK.SN MRK.PA MRK.MX MRK ENDP ABTCL.SN ABT.SN ABT 6MK.DE 0Y5F.L 096775.KS 096770.KS

Read more →